ARCHIVES

Parkinson Heads Oncology At Amgen

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007

Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments

April 19, 2013

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992

“The Working Group urges NCI to reconsider its current budget to determine whether the 25 percent devoted to the IRP is appropriate.”

July 7, 1995

Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release

April 26, 1985

Garb’s Questions, Answers About Cancer Program

December 12, 1980